{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:46:08Z","timestamp":1783529168746,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The debate surrounding systematic lymphadenectomy in the epithelial cancers of the ovary (EOC) was temporarily put to rest by the LION trial. However, there was a glaring disparity between the number of patients registered and the number of patients randomized suggesting inadvertent selection. A subsequent meta-analysis after this trial included all types of studies in the literature (randomized, non-randomized, case series, and, retrospective cohort), thus diluting the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a meta-analysis of hazard ratios of randomized controlled trials, to study the role of systematic para-aortic and pelvic lymph node dissection in the EOC. A detailed search of MEDLINE, Cochrane, and Embase databases was done to look for the published randomized controlled trials (RCT) comparing lymphadenectomy versus no lymphadenectomy in EOC. A meta-analysis of hazard ratios (HR) was performed for overall survival (OS) and progression-free survival (PFS) using fixed and random effect models. The quality of the RCTs was evaluated on Jadad\u2019s score, and the risk of bias was estimated by the Cochrane tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1342 patients with EOC were included for quantitative analysis. On meta-analysis, HR for PFS was 0.9 (95% CI 0.79\u20131.04) favoring lymphadenectomy. HR for OS was 1 (95% CI 0.84\u20131.18) signifying no benefit of systematic lymphadenectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results show a trend towards increased PFS which did not reach statistical significance nor translate into any meaningful benefit in OS. There is still a need for a greater number of well-conducted, suitably powered trials to convincingly answer this question.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12957-022-02835-4","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:13:11Z","timestamp":1669180391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials"],"prefix":"10.1186","volume":"20","author":[{"given":"Roli","family":"Purwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanshu K.","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"2835_CR1","first-page":"56","volume":"113","author":"JR Siewert","year":"1996","unstructured":"Siewert JR. Principles of radical surgery. Langenbecks Arch Chir Suppl Kongressband. 1996;113:56\u201363.","journal-title":"Langenbecks Arch Chir Suppl Kongressband"},{"issue":"12","key":"2835_CR2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/sj.bjc.6603803","volume":"96","author":"JK Chan","year":"2007","unstructured":"Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13\u2009918 patients. Br J Cancer. 2007;96(12):1817\u201322.","journal-title":"Br J Cancer"},{"issue":"25","key":"2835_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","volume":"312","author":"AR Feinstein","year":"1985","unstructured":"Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. N Engl J Med. 1985;312(25):1604\u20138.","journal-title":"N Engl J Med"},{"issue":"8","key":"2835_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/IGC.0000000000000514","volume":"25","author":"M Kleppe","year":"2015","unstructured":"Kleppe M, Kraima AC, Kruitwagen RFPM, Van Gorp T, Smit NN, van Munsteren JC, et al. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer. 2015;25(8):1405\u201314.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"2835_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822\u201332.","journal-title":"N Engl J Med"},{"key":"2835_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijsu.2018.02.006","volume":"52","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zhang WW, Zhang QH, He ZY, Sun JY, Chen QH, et al. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study. Int J Surg Lond Engl. 2018;52:11\u20135.","journal-title":"Int J Surg Lond Engl"},{"issue":"6","key":"2835_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","volume":"95","author":"A Maggioni","year":"2006","unstructured":"Maggioni A, Benedetti Panici P, Dell\u2019Anna T, Landoni F, Lissoni A, Pellegrino A, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95(6):699\u2013704.","journal-title":"Br J Cancer"},{"issue":"5","key":"2835_CR8","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e67","volume":"31","author":"T Chiyoda","year":"2020","unstructured":"Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, et al. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol. 2020;31(5):e67.","journal-title":"J Gynecol Oncol"},{"key":"2835_CR9","unstructured":"Guidelines Detail [Internet]. NCCN. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail. [Cited 2022 May 24]."},{"issue":"8","key":"2835_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97(8):560\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"2835_CR11","doi-asserted-by":"crossref","unstructured":"Appendix: Jadad Scale for Reporting Randomized Controlled Trials. In: Evidence-based Obstetric Anesthesia [Internet]. John Wiley & Sons, Ltd; 2005. 237\u20138. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9780470988343.app1. [Cited 2022 Feb 17].","DOI":"10.1002\/9780470988343.app1"},{"key":"2835_CR12","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011:343 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3196245\/. [Cited 2022 Mar 11].","DOI":"10.1136\/bmj.d5928"},{"issue":"1","key":"2835_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.","journal-title":"Trials."},{"key":"2835_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-21416-0_1","volume-title":"Meta-Analysis with R [Internet]","author":"G Schwarzer","year":"2015","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G. An introduction to meta-analysis in R. In: Schwarzer G, Carpenter JR, R\u00fccker G, editors. Meta-Analysis with R [Internet]. Cham: Springer International Publishing; 2015. p. 3\u201317. (Use R!). Available from: https:\/\/doi.org\/10.1007\/978-3-319-21416-0_1. [Cited 2022 Mar 11]."},{"issue":"24","key":"2835_CR15","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815\u201334.","journal-title":"Stat Med"},{"key":"2835_CR16","unstructured":"Survival analysis: a practical approach, 2nd Edition | Wiley [Internet]. Wiley.com. Available from: https:\/\/www.wiley.com\/en-ie\/Survival+Analysis%3A+A+Practical+Approach%2C+2nd+Edition-p-9780470870402. [Cited 2022 Mar 11]."},{"key":"2835_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ."},{"issue":"1","key":"2835_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12874-020-01094-9","volume":"20","author":"GM Tawfik","year":"2020","unstructured":"Tawfik GM, Giang HTN, Ghozy S, Altibi AM, Kandil H, Le HH, et al. Protocol registration issues of systematic review and meta-analysis studies: a survey of global researchers. BMC Med Res Methodol. 2020;20(1):213.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2835_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0950-3552(89)80051-3","volume":"3","author":"E Burghardt","year":"1989","unstructured":"Burghardt E, Winter R. The effect of chemotherapy on lymph node metastases in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989;3(1):167\u201371.","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"2","key":"2835_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/gyno.1998.4964","volume":"69","author":"G Baiocchi","year":"1998","unstructured":"Baiocchi G, Grosso G, di Re E, Fontanelli R, Raspagliesi F, di Re F. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol. 1998;69(2):151\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2835_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340.","journal-title":"N Engl J Med"},{"issue":"3","key":"2835_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1006\/gyno.1997.4633","volume":"65","author":"F Carnino","year":"1997","unstructured":"Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol. 1997;65(3):467\u201372.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2835_CR23","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248\u201359.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2835_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJM199903253401202","volume":"340","author":"JJ Bonenkamp","year":"1999","unstructured":"Bonenkamp JJ, Hermans J, Sasako M, Welvaart K, Songun I, Meyer S, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908\u201314.","journal-title":"N Engl J Med"},{"issue":"21","key":"2835_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010881","volume":"97","author":"H Tang","year":"2018","unstructured":"Tang H, Liu Y, Wang X, Guan L, Chen W, Jiang H, et al. Clear cell carcinoma of the ovary: clinicopathologic features and outcomes in a Chinese cohort. Medicine (Baltimore). 2018;97(21):e10881.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2835_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ijgc-2020-001656","volume":"31","author":"Y Iida","year":"2021","unstructured":"Iida Y, Okamoto A, Hollis RL, Gourley C, Herrington CS. Clear cell carcinoma of the ovary: a clinical and molecular perspective. Int J Gynecol Cancer. 2021;31(4):605\u201316.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"2835_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0090-8258(02)00156-7","volume":"88","author":"CM Ho","year":"2003","unstructured":"Ho CM, Chien TY, Shih BY, Huang SH. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2003;88(3):394\u20139.","journal-title":"Gynecol Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02835-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T15:41:08Z","timestamp":1701445268000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02835-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02835-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"27 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}